Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples